Novel loss-of-function mutation in BRCA2 gene identified in a Chinese female with a family history of ovarian cancer: A case report
Explore this paper's citation graph
Summary
A novel heterozygous insertion in BRCA2 gene, c.3195_3196insA, is discussed, in a 54-year-old Chinese female with hereditary ovarian cancer, which generates a premature stop codon at amino acid 1,076, which leads to a truncated BRC a2 protein instead of a wild-type BRCa2 protein with 3,418 amino acids.
- Type
- article
- Published
- 2019-01-21
- Cited by
- 0
- References
- 19
- Access
- Open access
- OpenAlex
- https://openalex.org/W30867769
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:76665443
Keywords
Geography
References
- Targeted High-Throughput DNA Sequencing for Gene Discovery in Retinitis Pigmentosa
- Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction
- Visualization of image data from cells to organisms
- BLOOD AMMONIA AND GLUTAMINE AS PREDICTORS OF HYPERAMMONEMIC CRISES IN UREA CYCLE DISORDER PATIENTS
- Individual genomes on the horizon.
- DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: neurofibromatosis type 1 gene as a model.
- Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR–based GS‐FLX sequencing
- BRCA1 and BRCA2: 1994 and beyond
- Global cancer statistics
- Meta-analysis of BRCA1 and BRCA2 penetrance.
- Statistical challenges associated with detecting copy number variations with next-generation sequencing
- Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
- A standardized framework for the validation and verification of clinical molecular genetic tests
- The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.
- Massively parallel sequencing of ataxia genes after array‐based enrichment
- Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients
- Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer
- BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
Cited by
No citing papers recorded for this paper.
Related papers
No related papers recorded.